308 related articles for article (PubMed ID: 32556865)
21. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
22. Nomogram predicting survival of hepatocellular carcinoma with portal vein tumour thrombus after curative resection.
Hu Y; You S; Yang Z; Cheng S
ANZ J Surg; 2019 Jan; 89(1-2):E20-E25. PubMed ID: 30117625
[TBL] [Abstract][Full Text] [Related]
23. Albumin-bilirubin grade-based nomogram of the BCLC system for personalized prognostic prediction in hepatocellular carcinoma.
Ho SY; Hsu CY; Liu PH; Hsia CY; Lei HJ; Huang YH; Ko CC; Su CW; Lee RC; Hou MC; Huo TI
Liver Int; 2020 Jan; 40(1):205-214. PubMed ID: 31505104
[TBL] [Abstract][Full Text] [Related]
24. Combined Hangzhou criteria with neutrophil-lymphocyte ratio is superior to other criteria in selecting liver transplantation candidates with HBV-related hepatocellular carcinoma.
Xiao GQ; Yang JY; Yan LN
Hepatobiliary Pancreat Dis Int; 2015 Dec; 14(6):588-95. PubMed ID: 26663006
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
26. Comparison of current staging systems for advanced hepatocellular carcinoma not amendable to locoregional therapy as inclusion criteria for clinical trials.
Li X; Dong M; Lin Q; Chen ZH; Ma XK; Xing YF; Wan XB; Wen JY; Wei L; Chen J; Wu XY
Asia Pac J Clin Oncol; 2013 Mar; 9(1):86-92. PubMed ID: 23279888
[TBL] [Abstract][Full Text] [Related]
27. A nomogram integrating hepatic reserve and tumor characteristics for hepatocellular carcinoma following curative liver resection.
Cai BB; Shi KQ; Li P; Chen BC; Shi L; Johnson PJ; Lai P; Toyoda H; Zhou MT
Clin Chim Acta; 2018 Oct; 485():187-194. PubMed ID: 29908940
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of gamma-glutamyl transpeptidase to lymphocyte count ratio in hepatocellular carcinoma patients with microvascular invasion.
Zhang H; Zhou Y; Li Y; Qin W; Zi Y; Liu Y; Qiu X; Xu H; Liao W; Huang Z
BMC Cancer; 2020 Feb; 20(1):132. PubMed ID: 32070301
[TBL] [Abstract][Full Text] [Related]
29. Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma.
Dong B; Zhang H; Duan Y; Yao S; Chen Y; Zhang C
J Transl Med; 2024 May; 22(1):455. PubMed ID: 38741163
[TBL] [Abstract][Full Text] [Related]
30. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma.
Wu MT; He SY; Chen SL; Li LF; He ZQ; Zhu YY; He X; Chen H
BMC Cancer; 2019 Jun; 19(1):538. PubMed ID: 31164099
[TBL] [Abstract][Full Text] [Related]
31. Development and validation of prognostic risk prediction models for hepatocellular carcinoma patients treated with immune checkpoint inhibitors based on a systematic review and meta-analysis of 47 cohorts.
Ma D; Liu M; Zhai X; Li X; Jin B; Liu Y
Front Immunol; 2023; 14():1215745. PubMed ID: 37520554
[TBL] [Abstract][Full Text] [Related]
32. A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.
Liu Q; Li J; Liu F; Yang W; Ding J; Chen W; Wei Y; Li B; Zheng L
Cancer Imaging; 2020 Nov; 20(1):82. PubMed ID: 33198809
[TBL] [Abstract][Full Text] [Related]
33. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
[TBL] [Abstract][Full Text] [Related]
34. Modified Child-Pugh grade
Huang F; Gao J
World J Gastroenterol; 2020 Feb; 26(7):749-758. PubMed ID: 32116422
[TBL] [Abstract][Full Text] [Related]
35. Significance of tumor-infiltrating immunocytes for predicting prognosis of hepatitis B virus-related hepatocellular carcinoma.
Chen QF; Li W; Wu PH; Shen LJ; Huang ZL
World J Gastroenterol; 2019 Sep; 25(35):5266-5282. PubMed ID: 31558872
[TBL] [Abstract][Full Text] [Related]
36. Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion.
Lee D; Lee HC; An J; Shim JH; Kim KM; Lim YS; Chung YH; Lee YS
Clin Mol Hepatol; 2018 Jun; 24(2):144-150. PubMed ID: 29665630
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of metabolic tumour volume on baseline
Shagera QA; Cheon GJ; Koh Y; Yoo MY; Kang KW; Lee DS; Kim EE; Yoon SS; Chung JK
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1417-1427. PubMed ID: 30941463
[TBL] [Abstract][Full Text] [Related]
38. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
[TBL] [Abstract][Full Text] [Related]
39. A new ALBI-based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma.
Lee IC; Hung YW; Liu CA; Lee RC; Su CW; Huo TI; Li CP; Chao Y; Lin HC; Hou MC; Huang YH
Liver Int; 2019 Sep; 39(9):1704-1712. PubMed ID: 31319016
[TBL] [Abstract][Full Text] [Related]
40. Comparing various scoring system for predicting overall survival according to treatment modalities in hepatocellular carcinoma focused on Platelet-albumin-bilirubin (PALBI) and albumin-bilirubin (ALBI) grade: A nationwide cohort study.
Lee SK; Song MJ; Kim SH; Park M
PLoS One; 2019; 14(5):e0216173. PubMed ID: 31048923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
